Projection of mesothelioma mortality in Britain using Bayesian methods

British Journal of Cancer

Volumn 103, Issue 3, 2010, Pages 430-436

  Tan, E ^a   Warren, N ^a   Darnton, A J ^b   Hodgson, J T ^b  

^a HEALTH AND SAFETY LABORATORY   (United Kingdom)

^b HEALTH AND SAFETY EXECUTIVE   (United Kingdom)

Author keywords

Bayesian; Great Britain; Markov Chain Monte Carlo; mesothelioma; mortality

Indexed keywords

ASBESTOS;

ADULT; ARTICLE; BAYES THEOREM; CANCER MORTALITY; CANCER RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; MONTE CARLO METHOD; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BAYES THEOREM; ENVIRONMENTAL EXPOSURE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MARKOV CHAINS; MESOTHELIOMA; MIDDLE AGED; MODELS, BIOLOGICAL; MONTE CARLO METHOD; POISSON DISTRIBUTION; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; SEX CHARACTERISTICS; TIME FACTORS; YOUNG ADULT;

EID: 77955053325     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605781     Document Type: Article

References (17)

1. Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S (2000) Future trends in mortality of French men from mesothelioma. Occup Environ Med 57: 488-494
2. Clements M, Berry G, Shi J, Ware S, Yates D, Johnson A (2007) Projected mesothelioma incidence in men in New South Wales. Occup Environ Med 64: 747-752
3. Doll R (1971) The age distribution of cancer: implications for models of carcinogenesis. J R Stat Soc Ser A 134: 133-166
4. Hastings WK (1970) Monte Carlo sampling methods using Markov chains and their applications. Biometrika 57: 97-109
5. Health and Safety Executive (2003) Mesothelioma Mortality in Great Britain: Estimating the Future Burden. Health and Safety Executive: Bootle, UK
6. Health Effects Institute (1991) Asbestos in Public and Commercial Buildings: A Literature Review and Synthesis of Current Knowledge. Health Effects Institute-Asbestos Research: Cambridge, MA.
7. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J (2005) The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 92: 587-593
8. HSE (2002) Amendment to the Control of Asbestos at Work Regulations 1987 and AcoP: Regulatory Impact Assessment. Health and Safety Executive: Bootle, UK Ilg AG
9. Bignon J, Valleron AJ (1998) Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med 55: 760-765
10. Leigh J, Driscoll T (2003) Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health 9: 206-217
11. McDonald JC, McDonald AD (1996) The epidemiology of mesothelioma in historical context. Euro Respir J 9: 1932-1942
12. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E (1953) Equations of state calculations by fast computing machines. J Chem Phys 21: 1087-1092
13. Peto J, Hodgson JT, Matthews FE, Jones JR (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345: 535-539
14. Peto J, Selikoff IJ (1982) Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer 45: 124-135
15. Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J (2009) Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer 100: 1175-1183
16. Segura O, Burdorf A, Looman C (2003) Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 60:50-55
17. Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED (2008) US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Canc Prev 17: 525-534